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Abstract
Objective Computed tomography (CT)-compatible robots,
both commercial and research-based, have been developed
with the intention of increasing the accuracy of needle place-
ment and potentially improving the outcomes of therapies in
addition to reducing clinical staff and patient exposure to
radiation during CT fluoroscopy. In the case of highly inac-
cessible lesions that require multiple plane angulations, robot-
ically assisted needles may improve biopsy access and
targeted drug delivery therapy by avoidance of the straight
line path of normal linear needles.
Methods We report our preliminary experience of performing
radiofrequency ablation of the liver using a robotic-assisted
CT guidance system on 11 patients (17 lesions).
Results/Conclusion Robotic-assisted planning and needle
placement appears to have high accuracy, is technically easier
than the non-robotic-assisted procedure, and involves a sig-
nificantly lower radiation dose to both patient and support
staff.
Key Points
• An early experience of robotic-assisted radiofrequency ab-
lation is reported
• Robotic-assisted RFA improves accuracy of hepatic lesion
targeting
• Robotic-assisted RFAmakes the procedure technically easier
with significant lower radiation dose
Keywords Robot . Radiofrequency ablation . Liver tumour .
CT-guided . Interventional radiology
Introduction
Computed tomography (CT)-compatible robots have been
developed and may soon be integrated into CT-guided renal
mass ablation, hopefully reducing the radiation exposure to
clinical staff and patients during CT fluoroscopy [1]. One
recent study compared a preoperative computer-assisted opti-
cal needle tracking navigation system (KOELIS®, Medtech
Inc, Grenoble, France) with a CT-mounted robotic needle
driver system (AcuBot®, Johns Hopkins University, Balti-
more, MD, USA) and found improved accuracy (mean target
distance 1.2 versus 5.8 mm, P<0.0001) and reduced targeting
time (37 versus 108 s, P<0.0001) for the CT-mounted robotic
needle driver system [2]. The authors demonstrated the po-
tential of robotic needle guidance to improve needle interven-
tions, demonstrating superiority over a commercial navigation
system.
Even newer robotic-based image-guided procedures are in
development including specialised robotically controlled
“steerable” needles that may allow for access to previously
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inaccessible anatomical structures for improved biopsy access
and targeted drug delivery therapy by avoidance of the straight
line path of normal linear needles [3]. The increasing com-
plexity invariable leads to increased cost of the devices and
there is a need to balance these conflicting aims.
We report our preliminary experience with a CT or PET-
CT-guided robotic positioning system (ROBIO™ EX, Perfint
Healthcare Pvt. Ltd, Florence, OR, USA), which is designed
to assist interventional radiologists in performing procedures
that require precise tool positioning. ROBIO™ EX is a
standalone positioning device that can bemoved to the desired
position along the patient table of the CT system. This device
has two linear motions to position the guide to the point of
interest and two angular motions to facilitate the angular entry
of the needle. The system offers several features to help
clinicians to target the tumour and plan for accurate tool
placement. It facilitates targeting and tool placement in deep-
seated lesions requiring orbital, cranio-caudal angulations or a
combination of both for thoracic, abdominal and pelvic inter-
ventional procedures.
Materials and methods
This study was granted with medical ethics approval (MEC
no. 949.9) from the Medical Ethics Committee, University of
Malaya Medical Centre, Kuala Lumpur, Malaysia.
Patients
A total of 11 patients with 17 lesions were treated with
radiofrequency ablation (RFA) with the guidance of the
ROBIO™ EX (Perfint Healthcare Pvt. Ltd, Florence, OR,
USA). Six patients had new and recurrent hepatocellular
carcinoma (HCC) and 5 patients had colorectal metastases.
Eight patients were treated with the Cool-tip RFA system
(Valleylab, Boulder, CO, USA) and 3 patients were treated
with the RITA StarBurst® system (Angiodynamics, Latham,
NY, USA). All the lesions were no greater than 3.0 cm in
maximum diameter (the average dimension of the tumour was
2.0×2.2 cm).
All the RFA procedures were performed under general
anaesthesia. Once the patients were intubated, they were
wrapped in reusable immobiliser to minimise patient move-
ment during the procedure. In order to optimise needle place-
ments, the baseline CT, verification of needle placement and
post-procedure CTwere performed at end expiration with the
airway disconnected from the ventilator. Additionally, to min-
imise liver excursion between the end expiration (when needle
placement was carried out) and the inspiration, the tidal vol-
umes were set at low with high respiratory rate and high O2
level. Further, to ensure that spontaneous breathing of the
patient would not affect the end expiratory phase, we used
muscle relaxants regularly especially when doing multiple
placements. Otherwise the loss of muscle paralysis would
impair the end tidal volume and place the liver at a much
lower level.
All the patients had non-contrast baseline CT to identify the
lesions. However in 6 patients, because the lesions were small,
contrast-enhanced CT studies (example shown in Fig. 1a)
were performed as the baseline to better delineate the location
of the lesions. Post-RFA three-phase CTs (Fig. 1d) were then
performed to assess the completion of the ablation as well as
to act as the baseline for subsequent follow-up. One patient,
however, did not have post-RFA CT because of renal
impairment.
ROBIO™ EX treatment planning
Following baseline CT, the lesions were identified. The CT
images were exported to the ROBIO™ EX workstation for
treatment planning. The target point (centre of the tumour
volume) as well as the entry point (needle puncture site on
skin surface) was determined by the interventional radi-
ologist. The angulations of the needle, the depth of the
lesion as well as the needle trajectory path were calcu-
lated by the ROBIO™ EX workstation and shown on
the treatment plan (Fig. 1b). The plan was carefully checked
by the radiologist to avoid critical organs or bone across the
trajectory. Once confirmed, the plan was sent to the robotic
arm for execution.
Robotic-assisted needle placement
Once the treatment plan was confirmed, the patient was posi-
tioned to the exact coordinates as shown in the ROBIO™ EX
treatment plan. The patient’s skin was prepared for the proce-
dure in the intended region. The robotic arm was then activat-
ed and it moved automatically to the planned coordinates as
determined in the treatment plan. Once the robotic arm was
completely halted at its position, the radiologist placed an
appropriate bush and bush holder at the end-effector of the
arm (Fig. 2). The skin and liver capsule along the projected
path of the RFA needle were infiltrated with 10 mL of 1 %
lignocaine. The radiologist then inserted the RFA needle
through the bush and pushed the needle to the predetermined
depth where the end-effector was located (Fig. 3). Upon
completion of the insertion of the RFA needle, the robotic
arm was detached from the needle and returned to its original
position. CT fluoroscopy (Fig. 1c) was performed to ensure
that the RFA needle was located within the tumour volume.
RFA therapy was then started and the completeness of the
ablation was determined by using multiphasic contrast-
enhanced CT immediately after the RFA.
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Data collection and analysis
The orbital and cranio-caudal angulations of the robotic arm
were recorded for each lesion targeted in all patients. The
number of adjustments of the RFA needle was documented.
Deviation of the tip from the centre of the targeted location
was recorded.
The performance level of the overall procedureswas assessed
by the interventional radiologist for each robotic-assisted RFA
on a five-point scale (5=excellent, 4=good, 3=average, 2=fair
and 1=poor). Any complications related to the use of the robot
or the RFAwere also recorded.
The CT fluoroscopic dose (DLP) received by the patients
during the needle placement and ablation was recorded. The
total dose from the whole procedure including the multiphasic
CT studies was also recorded as the CTDIvol. The doses were
then compared with a random historical control group of pa-
tients who had liver RFA performed by the same radiologist but
without using the assistance of a robot for needle placement.
Results
Radiofrequency ablation was successfully completed in 11
patients with 17 lesions. The deepest lesion was 13.7 cm and
the shallowest was 6.2 cm from the skin surface. The diameter
of the lesions ranged from 1.1 to 3.0 cm. The lesions were all
targeted successfully with the assistance of a robot. No repo-
sitioning of the needle was required in any of the patients. The
orbital angulations of the robotic arm ranged from −49.0° to
46.5° (mean negative angulation was −26.5±24.9°; mean
positive angulation was 27.3±12.0°). The cranio-caudal an-
gulations remained at 0° in 9 lesions (6 patients) whereas the
remaining 8 lesions (3 patients) had cranio-caudal angulations
of up to 25.0° (mean 7.4±9.9°).
Readjustments of the RFA needle were necessary in
6 lesions, with single readjustment in 4 lesions and two
readjustments in the remaining 2 lesions.
The total DLP and CTDIvol dose for the entire procedure
were 956.09±400.33 mGy cm and 258.00±125.46 mGy, re-
spectively. Compared with historical data from our standard
RFA procedure (n=30), the total DLP and CTDIvol dose were
1,703.93±1,152.37 mGy cm and 632.73±503.06 mGy,
respectively.
All patients had successful ablation confirmed on multi-
phasic contrast-enhanced CT except in one patient who had
renal impairment, which precluded contrast injections.
Post-RFA contrast-enhanced CT was performed in all ex-
cept one patient owing to renal impairment. The CT images
showed successful ablation of the targeted lesions in all pa-
tients. No complications related to either the robot or the RFA
were noted in this study.
The mean performance level rated for the robotic-assisted
RFA procedure was 4.6±0.5, in which the score 5 was
achieved in 7 patients and the score 4 was achieved in the
remaining 4 patients. The patients’ demography, treatment
protocols, radiation dose and evaluation of treatment outcomes
are summarized in Table 1.
Discussion
Image guidance techniques have revolutionised the perfor-
mance of interventions in medicine developed from the use
of advanced imaging investigations. These developments
have been adapted for neurosurgery, orthopaedic procedures,
urological surgery, etc. Current research into the combined
application of image-guided surgery and robots with the com-
plexities of soft tissue registration, operative navigation and
surgical use presents unique engineering challenges and new
knowledge requirements for interventional radiology.
Recent advances in robotically guided interventions have
been successful in assisting placement of needles or related
instruments for surgery or interventional procedures [4–9].
Magnetic resonance imaging (MRI)-compatible robots have
also been developed despite their significant engineering chal-
lenges and are continuing to be investigated for prostate biopsy
utilising the potential advantages of multiparametric MRI.
There may also be a future role for improving the accuracy
and precision of radioactive seed placement for prostate can-
cer using the interventional robotic device [10].
The robot used in this study was a CT- or PET-CT-guided
needle positioning system for interventional procedures. The
system calculates coordinates on DICOM images from CT or
PET-CT and guides the placement of the needle accurately
within the body using a robotic arm. The depth of needle
placement is pre-determined by the system but the operator
still has the option of varying this for increased safety. The
system can be used for tumour targeting for abdominal and
thoracic interventions, including biopsy, fine needle aspiration
cytology (FNAC), pain management, drainage and tumour
ablation.
Earlier robotic guidance devices required extensive instal-
lation and were often cumbersome and occupied a lot of space
in the operation room [6, 11, 12]. Devices that are time
consuming in terms of pre-arrangement and usage are eco-
nomically unattractive and are therefore not likely to be used
in daily routine. ROBIO™ EX requires minimal effort to be
mounted and registered to the CT device using the InstaReg™
technology (Perfint Healthcare Pvt Ltd., Florence, OR, USA).
The system is motorised and can be operated by one person.
These features reduced the complexity of the robotic-guided
procedure.
Localisation and navigation of the robots are usually
performed with optical or magnetic localisation spheres,
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requiring a pre-procedure import and processing of the 3D
data to the robot’s workstation, which can be a complex and
time-consuming procedure. However in our preliminary ex-
perience with the Robio™ EX, we found the overall satisfac-
tion with the performance to be high. Even though the plan-
ning did take time, it was found to be intuitive and this
increased time was compensated for by greater speed and
accuracy in placing the RFA needles.
Most importantly, the greater control and ease of needle
placement outside the bore of the CT gantry without exposure
to ionising radiation was a tremendous benefit. Both before and
during the needle insertion, neither direct exposure of the inter-
ventionist’s hands to the radiation beam was involved, nor was
the use of inaccurate holding devices such as forceps necessary.
During the conventional CT-guided RFA procedure, insertion
and placement of the RFA needle are performedmanually under
the guidance of real-time CT fluoroscopy. This challenging
procedure needs to be performed by an experienced interven-
tional radiologist and certain impreciseness during the manual
insertion is unavoidable. The continuous reassessment and re-
petitive corrections of the needle orientation under the guidance
of CT fluoroscopy could lead to an increase in radiation expo-
sure to the patients as well as the attending staff. Our study
showed a significant reduction of CT fluoroscopic dose in
patients of 43.9 % (DLP) and 59.2 % (CTDIvol) comparing
robotic and non-robotic-assisted RFA for HCC. This compari-
son might be biased because the radiation dosimetry data for
conventional RFA were collected from our historical HCC
patients in our hospital database. Further the interventional radi-
ologist who participated in this study was aware of the objec-
tive of dose assessment; therefore, there might be unintended
biasness in reducing the fluoroscopic dose. A randomised
controlled study with a larger sample size would be necessary
to confirm this.
Fig. 1 a Contrast-enhanced
baseline CT image shows solitary
colorectal metastases (26.2 mm
diameter) in segment VI. b
Reconstructed CT images (slice
thickness 1 mm) were sent to the
ROBIO™ EX workstation for
treatment planning. The
simulated needle trajectory path
was shown on the treatment plan
and verified by the radiologist. c
A CT fluoroscopy check was
carried out to verify the accuracy
of the needle placement within the
target volume. d Post-RFA three-
phase CTs to assess the
completeness of tumour ablation
Fig. 2 The robotic arm was positioned automatically to the exact coor-
dinates according to the treatment plan. The bush and bush holder were
clamped firmly at the end-effector of the robotic arm before insertion of
the RFA needle through the bush
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Althoughwe did not specifically measure the set-up time in
the patients treated, the interval between docking the device
until it was finally attached and powered up was less than
5 min. The time until the acquisition and planning were
completed took an average of another 10 min. Although there
is an initial set-up time for the robot and planning, this can be
compensated for by reduced need (or time) of needle reposi-
tioning using the manual method. Future analysis is proposed
to evaluate the time efficiency of the whole procedure.
We worked closely with anaesthetists in this study to opti-
mise needle placements. It was noted that performing all proce-
dures at the end of expiration with the airway disconnected from
ventilator produced consistent positing. Additionally using low
tidal volumes with high respiratory rate and high O2 was useful
to minimise liver excursion and needle movement in the cranio-
caudal direction. Further to ensure that spontaneous breathing of
the patient would not affect the end expiratory phase, we
ensured that muscle relaxants were used regularly especially
when doing multiple placements. Otherwise the loss of muscle
paralysis would impair the end tidal volume and place the liver
at a much lower level. The baseline CT, needle placement and
post-procedure CTacquisitions were all performed at the end of
expiration once the ventilator was disabled. Others have
suggested that anaesthetic manoeuvres, such as high frequency
jet ventilation, to reduce respiratory motion significantly reduce
radiation dose [13]. However these systems are expensive and
require a greater skill set.
There was nomultiplanar capability of the current ROBIO™
EX system and thus determining the centre of the lesion using
axial imaging may be limited. Also if there is more than a single
lesion, the operator needs to plan the subsequent treatments one
at time. Besides, the guidance software is also yet to compensate
for movements of the target region, especially those caused by
respiration as the planned trajectory is based on a static-acquired
3D data set. As the procedure was performed on patients under
arrested end expiration we were able to achieve more consistent
locations of the target lesions and hence accurate deployment of
the needles and measuring of the outcomes. The use of the
breath-holding systems to “fix” the location of the lesions to a
pre-determined point requires that the patients fully understand
and are able to cooperate completely with the requirements.
This would also add to the time required for training of the
patients before the actual procedure.
In addition, the use of robotic-assisted RFA may require a
change to the current workflow. Although it adds more steps to
the procedure (mainly done by the technician for device setup)
it does not bring any significant change in the clinical workflow
of the clinician.With free-hand CT-guided procedures, once the
studies have been viewed, the patient position can be deter-
mined. The radiographer would have done the baseline CT and
the physician would decide the best approach. Once that was
done the physician would localise the entry point using a laser
and under fluoroscopic guidance the procedure would be over
in less than 10 min in most circumstances. With the robot there
are several additional steps, which include docking the robotic
system, importing the images into the workstation, planning the
entry and target points, inputting the length of the needle, and
finally sending the information to the robotic arm. The robotic
arm would then move automatically to the accurate target
position for needle insertion. As a result, there would be a need
to redefine the roles of different members of the medical team
and the work flow chart. Also, the staff needs to being well
versed with the robot and its operation.
In conclusion, we present our early experience of robotic-
assisted CT-guided RFA for both primary and secondary liver
tumours. We have been able to show that the automated
system works well and could provide technical and diagnostic
success rates similar to those obtained with the manual meth-
od. Also, we found that the automated device decreased the
number of needle position adjustments and thereby minimised
the procedure time. The robotic device showed good accuracy
for percutaneous needle placement for RFA therapy with a
lower radiation dose compared with historical controls. From
our preliminary study we found that the robot provides high
accuracy with only a few readjustments required. Even though
these preliminary data were promising, the study was not
Fig. 3 The RFA needle was inserted by the radiologist through the bush
and the bush holder. The needle was then pushed to the predetermined depth
where the end-effector of the robotic arm was located. The robotic arm was
then detached from the RFA needle to allow a CT check of positioning
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randomised. In future a randomised study comparing the
robotic and non-robotic-assisted RFA needs to be carried out
with a larger sample size to determine the cost-effectiveness in
terms of time, cost and radiation dose to both patients and
operators. There is also a need for larger multi-centre studies
for cross-centre comparison.
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